Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


11.06.2018

1 Am J Clin Pathol
2 Blood
2 Cancer


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. FANG H, Kapoor P, Gonsalves WI, Frederick LA, et al
    Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
    Am J Clin Pathol. 2018 Jun 2. pii: 5032348. doi: 10.1093.
    PubMed     Text format     Abstract available


    Blood

  2. BOUDESCO C, Verhoeyen E, Martin L, Chassagne-Clement C, et al
    HSP110 sustains chronic NF-kappaB signaling in activated B cell diffuse large B cell lymphoma through MyD88 stabilization.
    Blood. 2018 Jun 5. pii: blood-2017-12-819706. doi: 10.1182/blood-2017-12-819706.
    PubMed     Text format     Abstract available

  3. ADAMS HJA, Kwee TC
    Benefit of brentuximab over bleomycin in first-line treatment of advanced-stage Hodgkin lymphoma has not been proven.
    Blood. 2018 Jun 1. pii: blood-2018-04-845438. doi: 10.1182/blood-2018-04-845438.
    PubMed     Text format    


    Cancer

  4. SORIGUE M, Sancho JM
    The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma.
    Cancer. 2018 Jun 7. doi: 10.1002/cncr.31565.
    PubMed     Text format    

  5. SUREDA A, Montoto S, Dreger P, Hamadani M, et al
    Reply to The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma.
    Cancer. 2018 Jun 7. doi: 10.1002/cncr.31564.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: